ストックスクリーナーアプリを入手
17.79
2.83%
0.49
アフターアワーズ：
17.96
0.17
+0.96%
前日終値:
$17.30
開ける：
$17.4
24時間の取引高:
6.25M
Relative Volume:
0.68
時価総額：
$9.19B
収益：
$11.32B
当期純損益:
$-981.00M
株価収益率:
-9.1081
EPS:
-1.9532
ネットキャッシュフロー:
$714.00M
1週間 パフォーマンス:
+1.48%
1か月 パフォーマンス:
-4.92%
6か月 パフォーマンス:
-1.98%
1年 パフォーマンス:
-43.81%
1日の値動き範囲:
$17.39
$17.95
1週間の範囲:
$17.09
$18.05
52週間の値動き範囲:
$15.73
$32.04
Baxter International Inc Stock (BAX) Company Profile
名前
Baxter International Inc
セクター
電話
(224) 948-2000
住所
ONE BAXTER PARKWAY, DEERFIELD, IL
Compare BAX vs ISRG, BDX, ALC, MDLN, RMD
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
BAX
Baxter International Inc
|
17.79 | 8.93B | 11.32B | -981.00M | 714.00M | -1.9532 |
ISRG
Intuitive Surgical Inc
|
439.92 | 149.15B | 10.58B | 3.00B | 2.83B | 8.2437 |
BDX
Becton Dickinson Co
|
142.35 | 39.53B | 21.37B | 1.41B | 3.07B | 3.9437 |
ALC
Alcon Inc
|
65.97 | 31.04B | 10.63B | 819.00M | 1.59B | 1.6577 |
MDLN
Medline Inc
|
36.02 | 30.60B | 29.14B | 1.07B | 1.05B | 1.1956 |
RMD
Resmed Inc
|
204.15 | 29.28B | 5.54B | 1.52B | 1.74B | 10.37 |
Baxter International Inc Stock (BAX) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-10-31 | ダウングレード | Argus | Buy → Hold |
| 2025-08-04 | ダウングレード | Stifel | Buy → Hold |
| 2025-08-01 | ダウングレード | Goldman | Buy → Neutral |
| 2025-02-26 | 再開されました | Goldman | Buy |
| 2025-02-24 | アップグレード | Argus | Hold → Buy |
| 2025-02-20 | 再開されました | Barclays | Overweight |
| 2024-07-15 | ダウングレード | Morgan Stanley | Equal-Weight → Underweight |
| 2024-05-30 | 開始されました | Goldman | Neutral |
| 2024-05-10 | ダウングレード | TD Cowen | Buy → Hold |
| 2023-05-30 | 再開されました | Morgan Stanley | Equal-Weight |
| 2023-03-29 | 開始されました | UBS | Neutral |
| 2023-01-06 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
| 2023-01-05 | ダウングレード | Raymond James | Outperform → Mkt Perform |
| 2023-01-03 | ダウングレード | BofA Securities | Buy → Neutral |
| 2022-12-19 | ダウングレード | JP Morgan | Overweight → Neutral |
| 2022-12-15 | ダウングレード | Deutsche Bank | Buy → Hold |
| 2022-12-12 | ダウングレード | Citigroup | Buy → Neutral |
| 2022-10-18 | 開始されました | Barclays | Overweight |
| 2022-10-12 | 開始されました | Jefferies | Hold |
| 2022-06-24 | ダウングレード | Wells Fargo | Overweight → Equal Weight |
| 2022-04-04 | ダウングレード | Goldman | Neutral → Sell |
| 2022-03-02 | 再開されました | BofA Securities | Buy |
| 2022-02-18 | 繰り返されました | KeyBanc Capital Markets | Overweight |
| 2022-02-18 | 繰り返されました | Morgan Stanley | Overweight |
| 2022-02-18 | 繰り返されました | Raymond James | Outperform |
| 2022-02-18 | 繰り返されました | Stifel | Buy |
| 2022-02-18 | 繰り返されました | UBS | Neutral |
| 2022-02-18 | 繰り返されました | Wells Fargo | Overweight |
| 2022-02-11 | 開始されました | Goldman | Neutral |
| 2022-01-07 | 再開されました | Citigroup | Buy |
| 2022-01-07 | アップグレード | Morgan Stanley | Equal-Weight → Overweight |
| 2021-09-13 | アップグレード | Cowen | Market Perform → Outperform |
| 2021-09-03 | アップグレード | Barclays | Equal Weight → Overweight |
| 2021-05-25 | 開始されました | Barclays | Equal Weight |
| 2021-01-29 | ダウングレード | Piper Sandler | Overweight → Neutral |
| 2021-01-06 | ダウングレード | UBS | Buy → Neutral |
| 2020-12-15 | ダウングレード | Goldman | Buy → Neutral |
| 2020-10-01 | アップグレード | Citigroup | Neutral → Buy |
| 2020-09-04 | ダウングレード | Argus | Buy → Hold |
| 2020-06-24 | 開始されました | Oppenheimer | Outperform |
| 2020-03-19 | アップグレード | Stifel | Hold → Buy |
| 2020-03-18 | アップグレード | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2020-03-05 | 開始されました | Citigroup | Neutral |
| 2020-02-13 | 開始されました | Goldman | Buy |
| 2020-01-02 | アップグレード | Evercore ISI | In-line → Outperform |
| 2019-12-17 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
| 2019-06-26 | 開始されました | KeyBanc Capital Markets | Sector Weight |
| 2019-04-08 | ダウングレード | Evercore ISI | Outperform → In-line |
| 2019-01-02 | アップグレード | Citigroup | Neutral → Buy |
| 2019-01-02 | アップグレード | Morgan Stanley | Underweight → Overweight |
| 2018-11-02 | アップグレード | Argus | Hold → Buy |
| 2018-10-16 | 開始されました | Barclays | Underweight |
| 2018-05-17 | 再開されました | Piper Jaffray | Overweight |
| 2018-02-06 | 繰り返されました | Citigroup | Neutral |
| 2018-01-03 | 開始されました | Evercore ISI | Outperform |
| 2018-01-03 | アップグレード | Raymond James | Mkt Perform → Outperform |
すべてを表示
Baxter International Inc (BAX) 最新ニュース
Baxter stock (US0673431090): FDA update puts focus on hospital-device demand - AD HOC NEWS
Baxter International Inc. stock outperforms competitors on strong trading day - MarketWatch
BAX (NYSE: BAX) affiliate files notice listing prior open-market purchases - Stock Titan
Is Baxter International (BAX) Pricing Reflect A Turn After Steep Multi Year Share Price Declines - Sahm
Baxter hosts manufacturing forum - Manufacturers' Monthly
Baxter International stock (US0673431090): News flow turns after fresh market moves - AD HOC NEWS
Baxter International earnings preview: What to expect - MSN
Baxter International stock (US0718131099): Q1 update highlights mixed sales and margin pressure - AD HOC NEWS
Baxter International Inc. stock underperforms Friday when compared to competitors - MarketWatch
BofA Securities Maintains Baxter International Inc(BAX.US) With Hold Rating, Maintains Target Price $24 - Moomoo
Baxter International Inc. stock (US0673431090): pharma supplier in focus after latest price swings - AD HOC NEWS
Baxter International shareholders approve board slate, pay and incentive plan at annual meeting - MSN
Baxter International stock (US0673431090): Gains 2.05% to $17.89 - AD HOC NEWS
Baxter International Inc. stock (US0673431090): Down 3.2% amid conference presentation - AD HOC NEWS
Baxter International stock outlook: Is Wall Street bullish or bearish? - MSN
First Pacific Advisors' Strategic Moves: Baxter International Inc. Takes Center Stage - GuruFocus
First Pacific Advisors's Baxter International Inc(BAX) Holding History - GuruFocus
Baxter International Inc (BAX) Stock Down 3.2% -- Now Undervalued? GF Score: 66/100 - GuruFocus
Artisan Value Income Fund's Baxter International Inc(BAX) Holding History - GuruFocus
Baxter International Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
Transcript : Baxter International Inc. Presents at Bank of America Global Healthcare Conference 2026, May-13-2026 11 - marketscreener.com
Baxter International Inc. stock (US0673431090): Recent 2% price gain on NYSE - AD HOC NEWS
Baxter International Inc. stock underperforms Tuesday when compared to competitors despite daily gains - MarketWatch
Baxter International Inc stock (US0718131099): Shares drop 2.56% to $17.53 - AD HOC NEWS
Baxter International Inc. stock underperforms Monday when compared to competitors - MarketWatch
Rare Hemophilia Factors Market Is Going to Boom |• Baxter International • Novo Nordisk • Pfizer - openPR.com
Baxter International Inc. stock (US0673431090): Q1 2026 earnings beat consensus - AD HOC NEWS
Manning & Napier Advisors LLC Sells 84,998 Shares of Baxter International Inc. $BAX - MarketBeat
Precision Trading with Baxter International Inc. (BAX) Risk Zones - Stock Traders Daily
Baxter International Shareholders Approve Board Slate, Pay and Incentive Plan at Annual Meeting - Barchart.com
Baxter International Inc. stock (US0673431090): Governance shake?up and earnings pressure in focus - AD HOC NEWS
Baxter International updates executive severance plan and amends bylaws after annual meeting - Investing.com India
Baxter Updates Executive Severance Plan and Governance Framework - TipRanks
Baxter (NYSE: BAX) expands severance protections and adds 20M incentive shares - Stock Titan
Infusion Therapy Market Is Going to Boom | Baxter International, B. Braun Melsungen AG, Fresenius Kabi AG - openPR.com
Baxter International Still Has A Path To Upside - Seeking Alpha
Director at Baxter (NYSE: BAX) receives 12,836 fully vested share award, now holds 37,076 - Stock Titan
Baxter (BAX) director Amy McBride receives 12,836-share fully vested stock grant - Stock Titan
Director at Baxter (NYSE: BAX) awarded 12,836 shares, holds 34,994 - Stock Titan
Baxter International (BAX) director awarded 12,836 fully vested shares - Stock Titan
Baxter (BAX) board chair David Brent Shafer receives 12,836-share stock grant - Stock Titan
Director Michael McDonnell of Baxter (NYSE: BAX) receives 12,836-share fully vested grant - Stock Titan
Director Jeffrey A. Craig receives 12,836 Baxter (BAX) shares in grant - Stock Titan
Baxter (NYSE: BAX) director awarded 12,836 fully vested shares in Form 4 - Stock Titan
MSN Money - MSN
Becton Dickinson at 13x Earnings: MedTech’s Most Mispriced Compounder - Investing.com
Baxter International Inc. stock rises Wednesday, still underperforms market - MarketWatch
FMR LLC reports 9.0% stake in Baxter International (BAX) — 46.3M shares - Stock Titan
Assessing Baxter International’s Valuation After Earnings Beat And Guidance Reaffirmation - simplywall.st
Pheochromocytoma Market to Reach USD 3.86 Billion by 2033 at 8.5% - openPR.com
Franklin Mutual U.S. Mid Cap Value Fund's Baxter International Inc(BAX) Holding History - GuruFocus
Baxter International Inc (BAX) 財務データ
収益
当期純利益
現金流量
EPS
0.97%
大文字化:
|
ボリューム (24 時間):